IBS Scientists (M&P and CAID groups, in collaboration with the IBS electron microscopy platform) have confirmed in PLOS Pathogens that the Covid virus can use immune cells to increase its transmission to other cells. They also showed that it is possible to inhibit this new mode of virus transmission by using glycomimetics, previously developed at IBS. This work is the result of an international collaboration with Spanish (Hospital Universitario 12 de Octubre, Madrid) and Italian (Universita degli Studi di Milano) groups. Press release